Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Mebeverine 50mg/5ml Sugar Free Oral Suspension
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Mebeverine hydrochloride may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
What it is and what it is used for
for Mebeverine oral suspension contains mebeverine which is an antispasmodic. It is used to treat the symptoms of a variety of bowel problems and works by relaxing the muscles in the gut, thereby relieving the symptoms of irritable bowel:
- colicky abdominal pain and cramps
- persistent diarrhoea where there is no obvious cause (this may or may not occur between bouts of constipation)
- wind. Mebeverine can also be used for spasm in the gut resulting from certain other diseases.
What you need to know before you take it
e Mebeverine Suspension Do not take Mebeverine Suspension
- if you are allergic to mebeverine or to any of the other ingredients of this medicine (listed in section 6). If this applies to you, speak to your doctor or pharmacist.
1
84/L/h/8
Other medicines and Mebeverine Suspension Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Some medicines may be affected by Mebeverine Suspension or they may affect how well Mebeverine Suspension will work. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Driving and using machines Mebeverine Suspension is unlikely to affect your ability to operate machinery or to drive. Mebeverine Suspension contains sodium, castor oil and sodium benzoate.
- sodium This medicinal product contains 61.5 mg of sodium (main component of cooking/table salt) in each 15 ml spoonful of oral suspension. This is equivalent to 3% of the WHO recommended daily intake of 2 g sodium for an adult.
- castor oil This may cause stomach upset and diarrhoea.
- sodium benzoate This medicine contains 30 mg sodium benzoate in each 15 ml spoonful of oral suspension which is equivalent to 2 mg/ml.
How to take it
Mebeverine Suspension Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Recommended doses Adults and children over 10 years of age The usual dose is 15 ml three times a day. The dose may be gradually reduced after a few weeks when your condition improves. Use in children under 10 years This medicine is NOT suitable for children under 10 years. Method of administration
- Shake the suspension before taking.
- Take the suspension preferably 20 minutes before meals to reduce symptoms after eating. If you take more Mebeverine Suspension than you should 1. Tell your doctor, pharmacist or nearest hospital casualty department immediately. 2. Take the bottle and any remaining suspension with you so that people can see what you have taken. 3. Do this even if you feel well.
2
84/L/h/8
If you forget to take Mebeverine Suspension If you forget to take a dose take it as soon as you remember, but if it is almost time for your next dose, skip the missed dose and continue as usual. Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this product, ask your doctor or pharmacist.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. STOP taking the suspension and seek medical help immediately if you have any of the following allergic reactions:
- difficulty breathing or swallowing, swelling of the face, lips, tongue or throat
- severe itching of the skin, with a red rash or raised lumps. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
How to store it
Mebeverine Suspension • • • • •
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle label and on the carton after EXP. The expiry date refers to the last day of that month. Do not store above 30°C. Keep container in the outer carton. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Contents of the pack and other information
What Mebeverine Suspension contains
- The active substance is mebeverine hydrochloride. Each 5 ml spoonful of oral suspension contains 50 mg mebeverine hydrochloride (as pamoate).
- The other ingredients are: microcrystalline cellulose, carmellose sodium, citric acid monohydrate, sodium citrate, polysorbate 20, polyoxyl 40 hydrogenated castor oil, disodium pamoate monohydrate, sodium benzoate (E 211), saccharin sodium, banana flavour, simethicone emulsion and purified water.
3
84/L/h/8
(See end of Section 2 for further information on sodium, castor oil and sodium benzoate). What Mebeverine Suspension looks like and contents of the pack Mebeverine Suspension is a yellow, banana flavoured suspension. It is available in amber glass bottles of 300 ml. Marketing Authorisation Holder Chemidex Pharma Ltd., trading as Essential Generics, 8a Crabtree Road, Egham, Surrey, TW20 8RN. Manufacturer Delpharm Bladel BV, Industrieweg 1, 5531 AD Bladel, The Netherlands. This leaflet was last revised in 07/2024
4
84/L/h/8
Frequently asked questions about Mebeverine 50mg/5ml Sugar Free Oral Suspension
How do I take Mebeverine 50mg/5ml Sugar Free Oral Suspension?
Mebeverine 50mg/5ml Sugar Free Oral Suspension comes as oral solution containing 50mg / 5ml. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
What is the active substance in Mebeverine 50mg/5ml Sugar Free Oral Suspension?
The active substance in Mebeverine 50mg/5ml Sugar Free Oral Suspension is mebeverine hydrochloride.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Mebeverine 50mg/5ml Sugar Free Oral Suspension, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Mebeverine 50mg/5ml Sugar Free Oral Suspension without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: mebeverine hydrochloride
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
1. For the symptomatic treatment of irritable bowel syndrome and other conditions usually included in this grouping, such as chronic irritable colon, spastic constipation, mucous colitis, spastic colitis. Mebeverine is effectively used to treat the symptoms of these conditions, such as colicky abdominal pain and cramps, persistent, non-specific diarrhoea (with or without alternating constipation) and flatulence.
2. For the symptomatic treatment of gastro-intestinal spasm secondary to organic diseases.
4.2. Posology and method of administration
Adults (including the elderly) and children 10 years and over: 15 ml (150 mg) three times a day, preferably 20 minutes before meals.
After a period of several weeks when the desired effect has been obtained, the dosage may be gradually reduced.
Children under 10 years. Not applicable.
4.3. Contraindications
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
4.4. Special warnings and precautions for use
Sodium benzoate
This medicinal product contains 30 mg sodium benzoate in each 15 ml spoonful of oral suspension which is equivalent to 2 mg/ml.
Polyoxyl 40 hydrogenated castor oil
This medicinal product contains 3 mg polyoxyl 40 hydrogenated castor oil in each 15 ml spoonful of oral suspension which is equivalent to 0.2 mg/ml. Castor oil may cause stomach upset and diarrhoea.
Sodium
This medicinal product contains 61.5 mg of sodium in each 15 ml spoonful of oral suspension, equivalent to 3% of the WHO recommended daily intake of 2 g sodium for an adult.
4.5. Interaction with other medicinal products and other forms of interaction
None known.
4.6. Fertility, pregnancy and lactation
Animal experiments have failed to show any teratogenic effects. However, the usual precautions concerning the administration of any drug during pregnancy should be observed.
4.7. Effects on ability to drive and use machines
Mebeverine has no or negligible influence on the ability to drive and use machines
4.8. Undesirable effects
Immune system disorders
Very rare (<1/10,000): hypersensitivity
Skin and subcutaneous tissue disorders
Very rare (<1/10,000): urticaria, angioedema, face oedema, exanthema/rash
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
4.9. Overdose
On theoretical grounds it may be predicted that CNS excitability will occur in cases of overdosage. No specific antidote is known; gastric lavage and symptomatic treatment is recommended.
🇷🇴 Known in Romania as
Medicines sold in Romania with the same active substance: Cunoscut în România ca
- DUSPATALIN 200 mg prescriptionMEBEVERINUM · taken by mouth
- COLOSPASMIN 100 mg drajeuri prescriptionMEBEVERINUM · taken by mouth
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
🇵🇱 Known in Poland as
Medicines sold in Poland with the same active substance: W Polsce znany jako
- Duspatalin GastroMebeverini hydrochloridum · taken by mouth
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
💬 Ask about this leaflet
Ask anything about Mebeverine 50mg/5ml Sugar Free Oral Suspension. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.